🔗 Permalink

Inventor profile of:

Gary Glick

City:

Ann Arbor, Michigan

Country:

United States

Published Applications:

Last publication date:

2024-11-28

Top Assignees for applications by Gary Glick

The entities that hold a legal rights for patent applications filed by inventor Glick Gary:

NOVARTIS AG 8 Basel, Switzerland
INNATE TUMOR IMMUNITY, INC. 5 Princeton, NJ United States
Innate Tumoir Immunity, Inc. 1 Princeton, NJ United States
NOVARTIS INFLAMMASOME RESEARCH, INC. 1 Cambridge, MA United States
IFM Due, Inc. 1 Boston, MA United States

Recent patent applications by Glick Gary

Gary Glick from Ann Arbor, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-11-28

US20240391884A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#2 | 2024-04-18

US20240122903A1

Human necessities

METHODS OF TREATING CANCER

#3 | 2024-03-28

US20240100017A1

Human necessities

METHODS OF TREATING CANCER

#4 | 2024-03-14

US20240083895A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#5 | 2024-02-22

US20240060982A1

Physics

METHODS OF TREATING CANCER

#6 | 2024-02-08

US20240041843A1

Human necessities

METHODS OF TREATING CANCER

#7 | 2023-12-28

US20230416211A1

Chemistry; metallurgy

Compounds and compositions for treating conditions associated with NLRP activity

#8 | 2023-06-22

US20230190684A1

Human necessities

METHODS OF TREATING COVID-19 WITH A NICLOSAMIDE COMPOUND

#9 | 2023-04-06

US20230107927A1

Chemistry; metallurgy

METHODS OF TREATING IATROGENIC AUTOIMMUNE COLITIS

#10 | 2023-04-06

US20230106899A1

Physics

METHODS OF TREATING CANCER

#11 | 2023-03-30

US20230099258A1

Chemistry; metallurgy

Compounds and compositions for treating conditions associated with NLRP activity

#12 | 2023-03-16

US20230079631A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#13 | 2023-03-02

US20230062815A1

Chemistry; metallurgy

Compounds and compositions for treating conditions associated with NLRP activity

#14 | 2023-02-23

US20230059136A1

Chemistry; metallurgy

THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#15 | 2023-02-16

US20230051589A1

Human necessities

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#16 | 2023-02-02

US20230031406A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#17 | 2022-10-27

US20220339169A1

Human necessities

METHODS OF TREATING OR SELECTING A TREATMENT FOR A SUBJECT RESISTANT TO TNF INHIBITOR USING A NLRP3 ANTAGONIST

#18 | 2022-08-25

US20220267276A1

Chemistry; metallurgy

NLRP MODULATORS

#19 | 2021-12-23

US20210395241A1

Chemistry; metallurgy

NLRP MODULATORS

#20 | 2021-08-05

US20210236466A1

Human necessities

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#21 | 2021-07-29

US20210230129A1

Chemistry; metallurgy

Compounds and compositions for treating conditions associated with NLRP activity

#22 | 2021-06-10

US20210171477A1

Chemistry; metallurgy

Compounds and compositions for treating conditions associated with NLRP activity

#23 | 2021-05-20

US20210147467A1

Chemistry; metallurgy

Compounds and compositions for treating conditions associated with sting activity

#24 | 2021-04-22

US20210114973A1

Chemistry; metallurgy

PHARMACEUTICAL FORMULATIONS

#25 | 2020-06-04

US20200172534A1

Chemistry; metallurgy

Compounds and compositions for treating conditions associated with STING activity

#26 | 2020-05-28

US20200165288A1

Chemistry; metallurgy

Compounds and compositions for treating conditions associated with sting activity

#27 | 2020-03-19

US20200087270A1

Chemistry; metallurgy

Compounds and compositions for treating conditions associated with NLRP activity

#28 | 2019-04-25

US20190119241A1

Chemistry; metallurgy

Compounds and compositions for treating conditions associated with NLRP activity

#29 | 2019-04-25

US20190119224A1

Chemistry; metallurgy

Compounds and compositions for treating conditions associated with NLRP activity

#30 | 2019-04-25

US20190119203A1

Chemistry; metallurgy

Compounds and compositions for treating conditions associated with NLRP activity

#31 | 2019-02-21

US20190055236A1

Chemistry; metallurgy

NLRP3 modulators

#32 | 2019-01-31

US20190031708A1

Chemistry; metallurgy

Cyclic dinucleotides for treating conditions associated with STING activity such as cancer

#33 | 2019-01-17

US20190016750A1

Chemistry; metallurgy

Cyclic dinucleotides for treating conditions associated with sting activity such as cancer

InventorID:

2402575 ⎘